Please login to the form below

Not currently logged in
Email:
Password:

Havas Just:: names Nicole Yost chief executive officer

Yost will replace Jennie Talman, who is stepping aside after 15 years

Specialist healthcare communications agency Havas Just:: has named Nicole Yost (pictured above) its new chief executive officer.

Yost will replace Havas Just:: co-founder Jennie Talman, who has been in the CEO role at the agency for 15 years.

While Yost will take the helm at Havas Just::, Talman will act as executive advisor to the agency and will remain involved in client business.

Yost has held leadership roles at Burson Cohn & Wolfe (BCW), Porter Novelli and Ogilvy Healthworld.

Most recently, she was responsible for establishing a new division at BCW, which focused on business transformation in the health sector.

“Havas Just:: has a strong reputation and a distinct personality. I am excited to be part of its future and am also looking forward to getting to know the team as well as my global colleagues in the Havas Health & You network,” commented Yost.

“Right now there is an opportunity to transform the relationship that pharma has with the public. My ambition is for Havas Just:: to play a critical role in helping our clients to shape the post-pandemic conversation around the provision and value of healthcare,” she added.

Article by
Lucy Parsons

20th February 2021

From: Marketing

Share

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Videum Health

Videum Health is a premium video platform that offers brands innovative engagement strategies to reach targeted healthcare audiences on a...

Latest intelligence

Personalised medicine: driving a need for greater diversity in clinical trials
Kate Shaw, Innovative Trials' Founder & CEO, investigates one of the biggest challenges facing clinical research today....
Congresses and conferences
Superstar congresses and conferences will stay centre stage but now share the limelight with virtual and hybrid events
With the pandemic having dimmed the lights on pharma conferences, their virtual and hybrid replacements have grasped the opportunity and are here to stay...
Cervical Cancer Prevention Month
In this first 2022 blog, the Innovative Trials' Equality & Diversity committee will be looking at raising awareness around Cervical Cancer...